Journal of International Oncology››2016,Vol. 43››Issue (8): 588-592.doi:10.3760/cma.j.issn.1673-422X.2016.08.007
Previous ArticlesNext Articles
Yan Haiya, Wang Jie
Online:
2016-08-08Published:
2016-07-05Contact:
Yan Haiya, Email: yanhaiya1976@126.com E-mail:yanhaiya1976@126.comYan Haiya, Wang Jie. The relationship among the expressions of vascular endothelial growth factor-C and its receptor and the cervical cancer growth and lymph node metastasis[J]. Journal of International Oncology, 2016, 43(8): 588-592.
[1] 纪常生. 早期宫颈癌微淋巴转移病理与临床的关系[J]. 中国实用医药, 2015, 10(2): 76-77. DOI: 10.14163/j.cnki.11-5547/r.2015.02.048. [2] Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma[J]. Expert Rev Anticancer Ther, 2015, 15(7): 805-810. DOI: 10.1586/14737140.2015.1047767. [3] 李淼, 闫风彩, 钱智, 等. 宫颈癌组织中Survivin、Ki-67及VEGF的表达及相关性[J]. 现代肿瘤医学, 2011, 19(7): 1396-1399. DOI: 10.3969/j.issn.1672-4992.2011.07.47. [4] Zhu P, Zhang J, Chen Q, et al. Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901[J]. Am J Surg, 2012, 204(1): 78-83. DOI: 10.1016/j.amjsurg.2011.06.056. [5] Wang TB, Wang J, Wei XQ, et al. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer [J]. Asia Pac J Clin Oncol, 2012, 8(2): 180-186. DOI: 10.1111/j.1743-7563.2011.01490.x. [6] Yu H, Zhang S, Zhang R, et al. The role of VEGF-C/D and Flt4 in the lymphatic metastasis of early-stage invasive cervical carcinoma[J]. J Exp Clin Cancer Res, 2009, 28: 98. DOI: 10.1186/1756-9966-28-98. [7] 侯亚超, 邓靖宇, 梁寒. VEGF-C/D及其受体与胃癌淋巴转移关系的研究进展[J]. 中国肿瘤临床, 2014, 41(24): 1608-1611. DOI: 10.3969/j.issn.1000-8179.20140407. [8] 沈飞琼, 魏素菊. VEGF-C及其受体VEGFR-2/3与肺癌关系的研究进展[J]. 实用癌症杂志, 2013, 28(4): 452-455. DOI: 10.3969/j.issn.1001-5930.2013.04.043. [9] 周晓琳. 肝癌组织中VEGF-C及其受体Fit-4的表达及意义[J]. 临床与实验病理学杂志, 2013, 29(3): 340-342. [10] Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti-and pro-angiogenic therapies[J]. Genes Cancer, 2011, 2(12): 1097-1105. DOI: 10.1177/1947601911423031. [11]Klasa-Mazurkiewicz D, Jarzab M, Milczek T, et al. Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients[J]. Pol J Pathol, 2011, 62(1): 31-40. [12]Chen Y, Jiang L, She F, et al. Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism[J]. Mol Cell Biochem, 2010, 345(1-2): 77-89. DOI: 10.1007/s11010-010-0562-y. [13]Chen H, Suo K, Cheng Y, et al. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase[J]. Gynecol Endocrinol, 2013, 29(1): 20-24. DOI: 10.3109/09513590.2012.705387. [14]Fujiwaki R, Hata K, Iida K, et al. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis[J]. Anticancer Res, 2000, 20(2B): 1317-1322. [15]孟琴, 纪新强. RKIP和VEGF在宫颈癌及癌前病变中表达的临床研究[J]. 山东医学高等专科学校学报, 2011, 33(2): 8790. DOI: 10.3969/j.issn.1674-0947.2011.02.004. [16]Tampouris AI, Kandiloros D, Giotakis I, et al. The role of the VEGF-C/-D/flt-4 autocrine loop in the pathogenesis of salivary neoplasms[J]. Pathol Res Pract, 2012, 208(3): 151-156. DOI: 10.1016/j.prp.2011.12.013. [17]Yu H, Zhang S, Zhang R, et al. The role of VEGF-C/D and Flt4 in the lymphatic metastasis of early-stage invasive cervical carcinoma[J]. J ExpClin Cancer Res, 2009, 28: 98. DOI: 10.1186/1756-9966-28-98. |
[1] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[2] | Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483. |
[3] | Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[4] | Zeng Liwu, Du Yuqiang, Zhang Peng, Tao Kaixiong.Progress in imaging evaluation of lateral lymph node metastasis in rectal cancer[J]. Journal of International Oncology, 2023, 50(4): 248-251. |
[5] | Ma Xueyan, Lu Lili, Sun Pengfei.Advances in the immune microenvironment in cervical cancer[J]. Journal of International Oncology, 2023, 50(1): 47-50. |
[6] | Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou.Advances in immunotherapy for recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2022, 49(9): 517-520. |
[7] | Shi Yingxia, Hu Lijun, Yu Jingping.Application of immune checkpoint inhibitors in the treatment of recurrent or metastatic cervical cancer[J]. Journal of International Oncology, 2022, 49(9): 568-571. |
[8] | Peng Chen, Xie Yintong, Zhang Xin, Xie Peng.Research progress of maintenance therapy for cervical cancer[J]. Journal of International Oncology, 2022, 49(7): 430-435. |
[9] | Yuan Chenyang, Zhou Juying.Research progress on prognostic factors of cervical cancer[J]. Journal of International Oncology, 2022, 49(5): 307-313. |
[10] | Wang Yue, Wu Qiong, Xu Yuan, Gong Wei, Xu Xiaoting.Screening and treatment progression of elderly cervical cancer[J]. Journal of International Oncology, 2022, 49(12): 754-758. |
[11] | Li Jinhao, Wang Guidong, Li Xuefei, Liu Zilin, Meng Kailong.Clinical study of venous phase CT value in predicting central group lymph node metastasis of papillary thyroid carcinoma[J]. Journal of International Oncology, 2022, 49(10): 581-585. |
[12] | Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min.Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells[J]. Journal of International Oncology, 2021, 48(4): 206-211. |
[13] | Yu Mingyue, Chen Zhengzheng, Zhao Xuxu, Ren Pingping, Zhang Ying, Ge Li, Zhu Meiling, Zhao Weidong.Factors related to postoperative adjuvant therapy of locally advanced cervical cancer and building of a nomogram prediction model[J]. Journal of International Oncology, 2021, 48(1): 35-40. |
[14] | Ding Xuchao, Cao Lili.Common active targeting nano drug delivery systems for cervical cancer[J]. Journal of International Oncology, 2021, 48(1): 61-64. |
[15] | Shu Hang, Xu Zhonghua, Zhu Haochen, Yang Yahui, Lyu Yin.Research progress of radiosensitivity in cervical cancer[J]. Journal of International Oncology, 2020, 47(8): 496-500. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||